TF
PFE icon

TIAA FSB’s Pfizer PFE Stock Holding History

TIAA FSB’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$19.3M Sell
525,207
-18,508
-3% -$720K 0.07% 114
2023
Q1 		$22.2M Sell
543,715
-267,498
-33% -$11.6M 0.08% 104
2022
Q4 		$41.6M Buy
811,213
+218,052
+37% +$10.5M 0.16% 80
2022
Q3 		$26M Sell
593,161
-25,369
-4% -$1.23M 0.11% 93
2022
Q2 		$32.4M Sell
618,530
-21,369
-3% -$1.09M 0.13% 85
2022
Q1 		$33M Sell
639,899
-12,353
-2% -$641K 0.11% 78
2021
Q4 		$38.4M Sell
652,252
-29,073
-4% -$1.44M 0.13% 75
2021
Q3 		$29.3M Sell
681,325
-20,699
-3% -$917K 0.1% 82
2021
Q2 		$27.5M Buy
702,024
+9,668
+1% +$376K 0.09% 86
2021
Q1 		$25.1M Sell
692,356
-14,785
-2% -$525K 0.09% 89
2020
Q4 		$26M Sell
707,141
-23,726
-3% -$870K 0.1% 81
2020
Q3 		$25.4M Buy
730,867
+10,168
+1% +$356K 0.11% 79
2020
Q2 		$22.4M Sell
720,699
-1,851
-0.3% -$62.9K 0.11% 78
2020
Q1 		$22.4M Sell
722,550
-29,473
-4% -$1M 0.13% 72
2019
Q4 		$28M Buy
752,023
+41,721
+6% +$1.49M 0.13% 73
2019
Q3 		$24.2M Sell
710,302
-29,021
-4% -$1.06M 0.13% 73
2019
Q2 		$30.4M Sell
739,323
-99,766
-12% -$3.96M 0.17% 60
2019
Q1 		$33.8M Sell
839,089
-149,616
-15% -$5.99M 0.27% 52
2018
Q4 		$40.9M Sell
988,705
-73,174
-7% -$3.04M 0.23% 47
2018
Q3 		$44.4M Buy
1,061,879
+28,485
+3% +$1.1M 0.23% 48
2018
Q2 		$35.6M Buy
1,033,394
+283,334
+38% +$9.68M 0.2% 51
2018
Q1 		$25.3M Sell
750,060
-49,740
-6% -$1.71M 0.14% 57
2017
Q4 		$27.5M Sell
799,800
-5,564
-0.7% -$190K 0.16% 55
2017
Q3 		$27.3M Buy
805,364
+28,357
+4% +$911K 0.17% 52
2017
Q2 		$24.8M Buy
+777,007
New +$24.5M 0.17% 56

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA FSB's PFE Position: Q2 2023 in Review

TIAA FSB reduced its Pfizer (PFE) stake by 3.4% in Q2 2023, selling an estimated $720K and leaving 525,207 shares worth $19.3M. The position accounts for 0.07% of the portfolio, ranked #114.

TIAA FSB first reported a position in PFE in Q2 2017 and has held it in 25 quarters since. The position peaked at $44.4M in Q3 2018. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • TIAA FSB held 525,207 shares of Pfizer worth $19.3M as of Q2 2023.
  • TIAA FSB sold 18,508 Pfizer shares in Q2 2023, an estimated $720K.
  • Pfizer made up 0.07% of TIAA FSB's portfolio in Q2 2023, its #114 holding.
  • TIAA FSB first reported a position in Pfizer in Q2 2017 and has held it in 25 quarters since.
  • TIAA FSB's Pfizer position peaked at $44.4M in Q3 2018.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.